Email
Password
Remember meForgot password?
    Log in with Twitter

pancreatic cancer patients News

New treatment extends life for pancreatic cancer patients

Gemcitabine and Abraxane, a variation of the old drug Taxol, are part of a 900-patient study in Arizona to treat pancreatic cancer. Currently, they are extending life by 1.8 months on the average patient diagnosed with advanced pancreatic cancer.
 

Search Digital Journal Archives


Set up a news alert for

pancreatic cancer patients


pancreatic cancer patients Image


Latest News
Top News